266 related articles for article (PubMed ID: 17108082)
1. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome.
McGill BE; Bundle SF; Yaylaoglu MB; Carson JP; Thaller C; Zoghbi HY
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18267-72. PubMed ID: 17108082
[TBL] [Abstract][Full Text] [Related]
2. Affective dysfunction in a mouse model of Rett syndrome: Therapeutic effects of environmental stimulation and physical activity.
Kondo MA; Gray LJ; Pelka GJ; Leang SK; Christodoulou J; Tam PP; Hannan AJ
Dev Neurobiol; 2016 Feb; 76(2):209-24. PubMed ID: 26019053
[TBL] [Abstract][Full Text] [Related]
3. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
4. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
5. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
[TBL] [Abstract][Full Text] [Related]
6. Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome.
De Filippis B; Ricceri L; Fuso A; Laviola G
Neuropharmacology; 2013 May; 68():174-83. PubMed ID: 22709945
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
8. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
9. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
10. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
[TBL] [Abstract][Full Text] [Related]
11. CpG methylation and the methyl CpG binding protein 2 (MeCP2) are required for restraining corticotropin releasing hormone (CRH) gene expression.
Bhave SA; Uht RM
Mol Cell Endocrinol; 2017 Oct; 454():158-164. PubMed ID: 28655627
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
13. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
14. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
15. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.
Kao FC; Su SH; Carlson GC; Liao W
Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106
[TBL] [Abstract][Full Text] [Related]
16. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome.
Samaco RC; Mandel-Brehm C; McGraw CM; Shaw CA; McGill BE; Zoghbi HY
Nat Genet; 2012 Jan; 44(2):206-11. PubMed ID: 22231481
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
[TBL] [Abstract][Full Text] [Related]
18. MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits.
Schaevitz LR; Gómez NB; Zhen DP; Berger-Sweeney JE
Genes Brain Behav; 2013 Oct; 12(7):732-40. PubMed ID: 24283265
[TBL] [Abstract][Full Text] [Related]
19. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
20. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
